Navigation Links
Neurocrine Biosciences Secures Committed Equity Financing Facility
Date:9/15/2009

subject to certain conditions, including a minimum share price threshold and the requirement that no individual tranche exceed $15 million. Kingsbridge may purchase shares of common stock pursuant to the CEFF at discounts ranging from 5 to 10 percent, depending on the average market price of Neurocrine's common stock during the applicable pricing period.

The CEFF does not impose any restrictions on Neurocrine's operating activities or capital raising alternatives, other than with respect to financings similar to the CEFF. During the term of the CEFF, Kingsbridge is prohibited from engaging in any short selling or derivative transactions related to Neurocrine's common stock.

The securities issuable pursuant to the CEFF have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration under the Securities Act of 1933 and applicable state securities laws or available exemptions from registration requirements. Neurocrine has agreed to file a registration statement with respect to the resale of shares issued pursuant to the CEFF within 60 days of the date of the CEFF agreement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. Any offering of Neurocrine's common stock under the registration statement referred to above will be made only by means of a prospectus.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irri
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
3. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
4. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
5. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
7. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
8. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Neurocrine Announces Work Force Restructuring
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...d., Nov. 30 Novavax, Inc...d enrollment in the Phase II clinical study of its...ed strains) VLP vaccine candidate in healthy adult...andomized, double-blind, active-controlled study i...icity of two different doses (15 mcg and 60 mcg) o...
(Date:11/30/2009)..., Nov. 30 Cell Therapeut...oday that its new class of platinum-based anti-tum...a stronger anti-tumor potency and activity compare...as well as the ability to overcome cisplatin-resis...ented in a paper titled "Novel Bis-platinum Comple...
(Date:11/30/2009)...LONDON, November 30 ApaTech, the r...urope,s fastest growing,Biotech/Pharmaceutical/Med...2009 Technology Fast 500 for EMEA (Europe, Middle ...s based on a companies, five-year revenue growth,...er this period. This,achievement places ApaTech 9t...
(Date:11/28/2009)... The Vanuatu National Advisory Committee on Climat...nication (SNC) Project in collaboration with the V.... of New Zealand have generated preliminary climat... the background for the country’s SNC report...Climate Change (UNFCCC). , ...
Breaking Biology Technology:NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
... Dr Albert J Ketterman and SHP Parakrama Karuna...ool of Hygiene and Tropical Medicine, Keppel St,...duction , In attempts to control Culex ... diseases such and filariasis and encephalitis, ...with organophosphate insecticides. However, mosqui...
... Bernd Eschweiler and Beate Kilb, Institute for..., Introduction , Bacterial dive...ed by , a characterization of isolated st...haracterization of microbial communities is the in... species present in the sample. Therefore isolated...
... Joseph W. Turek and Guy C. Le Breton, Departme...icago, College of Medicine, Chicago, IL 60612.,A...th Wolcott, Department,of Pharmacology M/C 868, ...12.,E-mail: jturek1@icarus.uic.edu , ...atelet thromboxane A 2 (TXA 2 ) receptor, in addi...
Other Biology Technology:Preparative Nondenaturing Gel Electrophoresis Used in the Purification of an Esterase Involved in Insecticide Resistance, Rev C 2Preparative Nondenaturing Gel Electrophoresis Used in the Purification of an Esterase Involved in Insecticide Resistance, Rev C 3Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 2Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 3Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 4Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 2Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 3Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 4Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 5
(Date:11/26/2009)... the Ocean,s most distinctive residents. ,Everyone...ad shape, says Michelle McComb from Florida Atlan... vision. ,Perhaps their visual field has been enha...ng the sharks excellent stereovision and depth per...two schools of thought on this theory. In 1942, G....
(Date:11/26/2009)..., 2009) Whitehead researchers have developed a ne...nt specific genes and proteins used by pathogens, ... human cell cultures genes are present in two copi... mother. Gene inactivation by mutation is therefor..., the second copy usually remains active and takes...
(Date:11/25/2009)...n the stomach, may be used to boost resistance to,...Yale School of Medicine researchers report in a st... Neuroscience . , Parkinson,s disease is caused ...f the midbrain known as the substantia nigra, whic... production of dopamine in late-stage Parkinson,s ...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2Scientists Spot How Sugar Feeds Tumors 54950 1MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 1MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 2MultiCell Technologies is Granted U S Patent for Immortalized Human Liver Cell Lines 4873 3China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31 2009 and the First Fi 13635 1China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31 2009 and the First Fi 13635 2
...THESDA, Md. (Feb. 24, 2009) − When participa... difficult exercise test, they reached exhaustion ...when mentally rested, a new study finds. , The st...he heart or muscles to perform any differently. In...each exhaustion. The researchers said the next ste...
...HINGTON, Feb. 23 Military, homeland security, law...hroughout the United States are being encouraged t...stration (FPED VII) in northern Virginia this May ...at Stafford County Regional Airport, just south of...arms and explosives survivability demonstrations w...
...LLEGE STATION This science may literally be outsi...field where thousands of tons of food are growing....t and kill the plants, wreaking havoc on the food ...finds the pathogen, experts can tell farmers how t...key. , That,s what scientists plan to do within t...
Other Biology News:Mental fatigue can affect physical endurance 2Mental fatigue can affect physical endurance 3Demonstration Targets Terrorism 2Portable kit may 1 day detect plant disease before disastrous outbreak 2Portable kit may 1 day detect plant disease before disastrous outbreak 3
...e TOPO Cloning Kits for Sequencing allow 5-minute ... The kits contain TOPO Cloning vectors with primer...PCR product insertion site. This minimizes the amo...ching the sequence of your insert.vectors are avai...
Carp Vitellogenin ELISA System from GE Healthcare, formerly Amersham Biosciences
Beacon 2000 Lamps from Invitrogen
...eate 100% capped transcripts with the translation ...er yields of 100% capped (versus 40% to 80% capped... messages in about 2 hours. mScript™ also feat...be up to 50% more efficient in in vivo tranlsation...
Biology Products: